Drug Type Small molecule drug |
Synonyms |
Mechanism Aurora A inhibitors(Serine/threonine-protein kinase Aurora-A inhibitors), Aurora B inhibitors(Serine/threonine-protein kinase Aurora-B inhibitors), Aurora C inhibitors(Serine/threonine-protein kinase Aurora-C inhibitors) + [1] |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H30N6O3 |
InChIKeyXKFTZKGMDDZMJI-HSZRJFAPSA-N |
CAS Registry827318-97-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Philadelphia chromosome positive chronic myelogenous leukemia | Phase 2 | - | - | |
Neuroblastoma | Preclinical | IT | 26 Mar 2017 | |
Small Cell Lung Cancer | Preclinical | IT | 26 Feb 2017 | |
Multiple Myeloma | Preclinical | US | 01 Oct 2008 | |
Multiple Myeloma | Preclinical | FR | 01 Oct 2008 | |
Castration-Resistant Prostatic Cancer | Preclinical | NL | 07 Feb 2008 | |
Metastatic castration-resistant prostate cancer | Preclinical | IT | 01 Sep 2007 |
Phase 2 | 56 | (xahxzvmkef) = bdrtmemamg fohaauxkcn (iidaaiprdc ) View more | - | 20 May 2013 | |||
Phase 2 | 43 | (gzaxsqbvjt) = wahncgthkv omgvioftql (cdqtpqcihm, 10.86 - 15.14) | - | 20 May 2011 | |||
(gzaxsqbvjt) = fwlhjoxlpc omgvioftql (cdqtpqcihm, 10.71 - 17.29) | |||||||
Phase 1 | 40 | (kenkpbpuzn) = twtshgadmf cdxftravqo (vpfzinfrkr ) View more | - | 20 May 2008 |